CN-72X series

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCN-72X series
Drug Alias Nameoncolytic adenovirus therapy 2 (Calydon)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalydon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalydon Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A